Recombinant multi-species SRRM2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SRRM2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Enables C2H2 zinc finger domain binding activity. Involved in mRNA splicing, via spliceosome. Located in Cajal body and nuclear speck. Part of U2-type catalytic step 2 spliceosome and U2-type precatalytic spliceosome. Implicated in autosomal dominant intellectual developmental disorder. Biomarker of Parkinson's disease. [provided by Alliance of Genome Resources, Feb 2025]
The Alternative Names of target: 300 kDa nuclear matrix antigen,300-KD,5033413A03Rik,CWF21,Cwc21,HSPC075,MRD72,SRL300,SRRM2,SRm300,Ser/Arg-related nuclear matrix protein of 300 kDa),Serine/arginine repetitive matrix protein 2,Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa (SR-related nuclear matrix protein of 300 kDa,Splicing coactivator subunit SRm300,Srrm2,Tax-responsive enhancer element-binding protein 803 (TaxREB803),mKIAA0324

Target products collectionGo to SRRM2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP6912-Ag-1/ GM-Tg-hg-IP6912-Ag-2 Human SRRM2 protein Human
GM-Tg-rg-IP6912-Ag-1/ GM-Tg-rg-IP6912-Ag-2 Rat SRRM2 protein Rat
GM-Tg-mg-IP6912-Ag-1/ GM-Tg-mg-IP6912-Ag-2 Mouse SRRM2 protein Mouse
GM-Tg-cynog-IP6912-Ag-1/ GM-Tg-cynog-IP6912-Ag-2 Cynomolgus/Rhesus macaque SRRM2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP6912-Ag-1/ GM-Tg-felg-IP6912-Ag-2 Feline SRRM2 protein Feline
GM-Tg-cang-IP6912-Ag-1/ GM-Tg-cang-IP6912-Ag-2 Canine SRRM2 protein Canine
GM-Tg-bovg-IP6912-Ag-1/ GM-Tg-bovg-IP6912-Ag-2 Bovine SRRM2 protein Bovine
GM-Tg-equg-IP6912-Ag-1/ GM-Tg-equg-IP6912-Ag-2 Equine SRRM2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP6912-Ag-1/ GM-Tg-hg-IP6912-Ag-2; GM-Tg-rg-IP6912-Ag-1/ GM-Tg-rg-IP6912-Ag-2;
GM-Tg-mg-IP6912-Ag-1/ GM-Tg-mg-IP6912-Ag-2; GM-Tg-cynog-IP6912-Ag-1/ GM-Tg-cynog-IP6912-Ag-2;
GM-Tg-felg-IP6912-Ag-1/ GM-Tg-felg-IP6912-Ag-2; GM-Tg-cang-IP6912-Ag-1/ GM-Tg-cang-IP6912-Ag-2;
GM-Tg-bovg-IP6912-Ag-1/ GM-Tg-bovg-IP6912-Ag-2; GM-Tg-equg-IP6912-Ag-1/ GM-Tg-equg-IP6912-Ag-2
Products Name SRRM2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name SRRM2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SRRM2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.